Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Sep 4;83(7):858–862. doi: 10.1054/bjoc.2000.1397

Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primaryon-small-cell lung cancer

T Moriya 1, Y Takiguchi 1, H Tabeta 2, R Watanabe 1, H Kimura 1, K Nagao 3, T Kuriyama 1
PMCID: PMC2374680  PMID: 10970685

Abstract

Malignant pericarditis, when associated with massive pericardial effusion, presents a critical condition in lung cancer patients. Because this condition often arises in terminally ill patients, intensive therapy such as multi-drug combination chemotherapy is rarely appropriate. This study evaluated the clinical relevance of intrapericardial administration of carboplatin for controlling malignant pericardial effusions associated with non-small-cell lung carcinoma (NSCLC). The method used for 10 eligible patients consisted of draining the pericardial effusion and infusing 300 mg/body of carboplatin in 50 ml of saline through an in-place catheter into the pericardial space and clamping the catheter for 40 min. Nine of the 10 patients showed satisfactory results, and 8 experienced complete regression of the effusion. No major or minor adverse effects were observed. Pharmacokinetics analysis revealed that the concentration of free platinum in the pericardial fluid was very high while that of total platinum in the circulating plasma was very low, assuring the usefulness of the intrapericardial instillation of carboplatin in terminally ill patients for controlling malignant pericardial effusion when the systemic delivery of cytotoxic agents is inappropriate. © 2000 Cancer Research Campaign

Keywords: cardiac tamponade, pericardial effusion, malignant pericarditis, lung cancer, carboplatin, pharmacokinetics

Full Text

The Full Text of this article is available as a PDF (71.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Calvert A. H., Harland S. J., Newell D. R., Siddik Z. H., Jones A. C., McElwain T. J., Raju S., Wiltshaw E., Smith I. E., Baker J. M. Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol. 1982;9(3):140–147. doi: 10.1007/BF00257742. [DOI] [PubMed] [Google Scholar]
  2. Celermajer D. S., Boyer M. J., Bailey B. P., Tattersall M. H. Pericardiocentesis for symptomatic malignant pericardial effusion: a study of 36 patients. Med J Aust. 1991 Jan 7;154(1):19–22. doi: 10.5694/j.1326-5377.1991.tb112840.x. [DOI] [PubMed] [Google Scholar]
  3. Colleoni M., Martinelli G., Beretta F., Marone C., Gallino A., Fontana M., Graffeo R., Zampino G., De Pas T., Cipolla G. Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen. J Clin Oncol. 1998 Jul;16(7):2371–2376. doi: 10.1200/JCO.1998.16.7.2371. [DOI] [PubMed] [Google Scholar]
  4. Curt G. A., Grygiel J. J., Corden B. J., Ozols R. F., Weiss R. B., Tell D. T., Myers C. E., Collins J. M. A phase I and pharmacokinetic study of diamminecyclobutane-dicarboxylatoplatinum (NSC 241240). Cancer Res. 1983 Sep;43(9):4470–4473. [PubMed] [Google Scholar]
  5. Davis S., Rambotti P., Grignani F. Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: an analysis of thirty-three cases. J Clin Oncol. 1984 Jun;2(6):631–636. doi: 10.1200/JCO.1984.2.6.631. [DOI] [PubMed] [Google Scholar]
  6. Dempke W., Firusian N. Treatment of malignant pericardial effusion with 32P-colloid. Br J Cancer. 1999 Aug;80(12):1955–1957. doi: 10.1038/sj.bjc.6690625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fiorentino M. V., Daniele O., Morandi P., Aversa S. M., Ghiotto C., Paccagnella A., Fornasiero A. Intrapericardial instillation of platin in malignant pericardial effusion. Cancer. 1988 Nov 1;62(9):1904–1906. doi: 10.1002/1097-0142(19881101)62:9<1904::aid-cncr2820620906>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  8. Go R. S., Adjei A. A. Review of the comparative pharmacology and clinical activity of cisplatin and carboplatin. J Clin Oncol. 1999 Jan;17(1):409–422. doi: 10.1200/JCO.1999.17.1.409. [DOI] [PubMed] [Google Scholar]
  9. Gotoh T., Fujita Y., Uchiyama H., Arimoto T., Sakai M., Kida T., Fujii T., Hiramori N., Iwasaki Y., Nakamura T. [Successful treatment of intrapericardial administration of carboplatin in a case of squamous cell lung cancer with malignant pericardial effusion]. Gan To Kagaku Ryoho. 1991 Oct;18(13):2337–2340. [PubMed] [Google Scholar]
  10. Herrstedt J., Clementsen P., Hansen O. P. Increased myelosuppression during cytostatic treatment and pleural effusion in patients with small cell lung cancer. Eur J Cancer. 1992;28A(6-7):1070–1073. doi: 10.1016/0959-8049(92)90459-f. [DOI] [PubMed] [Google Scholar]
  11. Lee L. N., Yang P. C., Chang D. B., Yu C. J., Ko J. C., Liaw Y. S., Wu R. G., Luh K. T. Ultrasound guided pericardial drainage and intrapericardial instillation of mitomycin C for malignant pericardial effusion. Thorax. 1994 Jun;49(6):594–595. doi: 10.1136/thx.49.6.594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lerner-Tung M. B., Chang A. Y., Ong L. S., Kreiser D. Pharmacokinetics of intrapericardial administration of 5-fluorouracil. Cancer Chemother Pharmacol. 1997;40(4):318–320. doi: 10.1007/s002800050663. [DOI] [PubMed] [Google Scholar]
  13. Liu G., Crump M., Goss P. E., Dancey J., Shepherd F. A. Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade. J Clin Oncol. 1996 Dec;14(12):3141–3147. doi: 10.1200/JCO.1996.14.12.3141. [DOI] [PubMed] [Google Scholar]
  14. Livingston R. B., McCracken J. D., Trauth C. J., Chen T. Isolated pleural effusion in small cell lung carcinoma: favorable prognosis. A review of the Southwest Oncology Group experience. Chest. 1982 Feb;81(2):208–211. doi: 10.1378/chest.81.2.208. [DOI] [PubMed] [Google Scholar]
  15. Lokich J., Anderson N. Carboplatin versus cisplatin in solid tumors: an analysis of the literature. Ann Oncol. 1998 Jan;9(1):13–21. doi: 10.1023/a:1008215213739. [DOI] [PubMed] [Google Scholar]
  16. Maher E. A., Shepherd F. A., Todd T. J. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg. 1996 Sep;112(3):637–643. doi: 10.1016/S0022-5223(96)70046-6. [DOI] [PubMed] [Google Scholar]
  17. Okamoto H., Shinkai T., Yamakido M., Saijo N. Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion. Cancer. 1993 Jan 1;71(1):93–98. doi: 10.1002/1097-0142(19930101)71:1<93::aid-cncr2820710115>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  18. Patton T. F., Himmelstein K. J., Belt R., Bannister S. J., Sternson L. A., Repta A. J. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep. 1978 Sep;62(9):1359–1362. [PubMed] [Google Scholar]
  19. Pera M. F., Jr, Harder H. C. Analysis for platinum in biological material by flameless atomic absorption spectrometry. Clin Chem. 1977 Jul;23(7):1245–1249. [PubMed] [Google Scholar]
  20. Press O. W., Livingston R. Management of malignant pericardial effusion and tamponade. JAMA. 1987 Feb 27;257(8):1088–1092. [PubMed] [Google Scholar]
  21. Shepherd F. A., Morgan C., Evans W. K., Ginsberg J. F., Watt D., Murphy K. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol. 1987 Nov 15;60(14):1161–1166. doi: 10.1016/0002-9149(87)90411-5. [DOI] [PubMed] [Google Scholar]
  22. Smith F. E., Lane M., Hudgins P. T. Conservative management of malignant pericardial effusion. Cancer. 1974 Jan;33(1):47–57. doi: 10.1002/1097-0142(197401)33:1<47::aid-cncr2820330110>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  23. Souquet P. J., Chauvin F., Boissel J. P., Cellerino R., Cormier Y., Ganz P. A., Kaasa S., Pater J. L., Quoix E., Rapp E. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis. Lancet. 1993 Jul 3;342(8862):19–21. doi: 10.1016/0140-6736(93)91882-m. [DOI] [PubMed] [Google Scholar]
  24. Takahashi H., Sasaki Y., Saijo N., Sakurai M., Nakano H., Nakagawa K., Hoshi A., Jett J. R., Hong W. S. In vitro colony inhibition of carboplatin against stomach and lung cancer cell lines in comparison with cisplatin. Cancer Chemother Pharmacol. 1987;19(3):197–200. doi: 10.1007/BF00252972. [DOI] [PubMed] [Google Scholar]
  25. Takahashi J., Kinomura S., Abe Y., Yoshioka S., Yambe T., Ono S., Ito H., Fukuda H., Yamada K., Sato T. [Two cases of malignant effusion treated successfully by loco-regional administration of carboplatin]. Gan To Kagaku Ryoho. 1994 Dec;21(16):2817–2820. [PubMed] [Google Scholar]
  26. Tomkowski W. Z., Filipecki S. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion in the course of the lung cancer. Lung Cancer. 1997 Mar;16(2-3):215–222. doi: 10.1016/s0169-5002(96)00631-9. [DOI] [PubMed] [Google Scholar]
  27. Tomkowski W., Szturmowicz M., Fijalkowska A., Filipecki S., Figura-Chojak E. Intrapericardial cisplatin for the management of patients with large malignant pericardial effusion. J Cancer Res Clin Oncol. 1994;120(7):434–436. doi: 10.1007/BF01240144. [DOI] [PubMed] [Google Scholar]
  28. Vaitkus P. T., Herrmann H. C., LeWinter M. M. Treatment of malignant pericardial effusion. JAMA. 1994 Jul 6;272(1):59–64. [PubMed] [Google Scholar]
  29. Van Echo D. A., Egorin M. J., Whitacre M. Y., Olman E. A., Aisner J. Phase I clinical and pharmacologic trial of carboplatin daily for 5 days. Cancer Treat Rep. 1984 Sep;68(9):1103–1114. [PubMed] [Google Scholar]
  30. Woods R. L., Williams C. J., Levi J., Page J., Bell D., Byrne M., Kerestes Z. L. A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer. 1990 Apr;61(4):608–611. doi: 10.1038/bjc.1990.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Yano T., Yokoyama H., Inoue T., Takanashi N., Asoh H., Ichinose Y. A simple technique to manage malignant pericardial effusion with a local instillation of bleomycin in non-small cell carcinoma of the lung. Oncology. 1994 Nov-Dec;51(6):507–509. doi: 10.1159/000227394. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES